Alpha Tau Medical Ltd.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-10upcoming | -0.14 | — | — |
| 2026-05-18 | -0.12 | -0.26 | -110.42% |
| 2026-03-09 | -0.12 | -0.14 | -13.35% |
| 2025-11-20 | -0.12 | -0.14 | -21.37% |
| 2025-08-11 | -0.11 | -0.13 | -13.75% |
| 2025-05-19 | -0.13 | -0.12 | +5.77% |
| 2025-03-12 | -0.13 | -0.13 | -2.63% |
| 2024-11-19 | -0.12 | -0.10 | +16.87% |
| 2024-08-14 | -0.12 | -0.11 | +11.46% |
| 2024-05-20 | -0.13 | -0.11 | +12.89% |
| 2024-03-07 | -0.12 | -0.11 | +6.67% |
| 2023-11-16 | -0.12 | -0.25 | -108.33% |
| 2023-08-28 | -0.13 | -0.12 | +5.88% |
| 2023-05-23 | -0.11 | -0.12 | -8.88% |
| 2023-03-09 | -0.11 | -0.04 | +64.03% |
| 2022-11-22 | -0.12 | -0.04 | +65.74% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DRTS | +26.81% | +53.18% | +118.79% | +262.81% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +23.85% | +57.82% | +122.23% | +250.13% |